Abaxis, Inc. CEO to Present at the Eighth Annual Forbes Global CEO Conference in Singapore
03 9월 2008 - 2:00AM
PR Newswire (US)
UNION CITY, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Abaxis, Inc.
(NASDAQ:ABAX), a medical products company manufacturing
point-of-care blood analysis systems, announced today that Clint
Severson, CEO and President, will participate in the Forbes Global
CEO Conference "Best Under a Billion" panel on Tuesday, September
9, 2008 at the Shangri-La Hotel in Singapore. About Abaxis Abaxis
develops, manufactures and markets portable blood analysis systems
for use in any veterinary or human patient-care setting to provide
clinicians with rapid blood constituent measurements. The system
consists of a compact, 5.1 kilogram (11.2 pounds), portable
analyzer and a series of single-use plastic discs, called reagent
discs that contain all the chemicals required to perform a panel of
up to 13 tests on veterinary patients and 14 tests on human
patients. The system can be operated with minimal training and
performs multiple routine tests on whole blood, serum or plasma
samples. The system provides test results in less than 12 minutes
with the precision and accuracy equivalent to a clinical laboratory
analyzer. Contact: Clint Severson Lytham Partners, LLC Chief
Executive Officer Joe Dorame, Joe Diaz & Robert Blum ABAXIS,
Inc. 602-889-9700 510-675-6500 DATASOURCE: Abaxis, Inc. CONTACT:
Clint Severson, Chief Executive Officer of ABAXIS, Inc.,
+1-510-675-6500; or Joe Dorame, Joe Diaz & Robert Blum, all of
Lytham Partners, LLC, +1-602-889-9700, for ABAXIS, Inc.
Copyright
Abaxis, Inc. (delisted) (NASDAQ:ABAX)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Abaxis, Inc. (delisted) (NASDAQ:ABAX)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
Abaxis, Inc. (delisted) (나스닥)의 실시간 뉴스: 최근 기사 0
More Abaxis (MM) News Articles